文献速递银屑病与炎症性皮肤病自身免疫性与大疱性皮肤病

化脓性汗腺炎与吸烟、肥胖、银屑病、炎症性肠病及系统性硬化的两样本孟德尔随机化研究

Hidradenitis Suppurativa and Smoking, Obesity, Psoriasis, Inflammatory Bowel Disease, and Systemic Sclerosis: Results From A 2-Sample Mendelian Randomization Study.
PubMed 文献 · JAMA Dermatol · 2026-01-01

该研究采用两样本孟德尔随机化方法,基于欧洲人群大样本GWAS数据,评估BMI、吸烟、银屑病、炎症性肠病(IBD)和系统性硬化(SSc)对化脓性汗腺炎(HS)的因果效应。结果支持BMI升高和IBD对HS存在因果效应,吸烟的因果估计在敏感性分析中不确定,银屑病和SSc未见因果证据。

要点

  • BMI升高与HS风险增加存在因果关联(每单位BMI OR=1.20)。
  • IBD对HS存在因果效应(OR=1.20),提示共病筛查价值。
  • 吸烟因果证据不确定,银屑病和SSc未显示因果效应。

核心结论

  • 研究提示IBD和BMI升高对化脓性汗腺炎风险存在因果效应。
  • 该信息有助于医生告知患者可改变生活方式行为相关的疾病风险,利于规划生活方式干预。

研究设计与样本

  • 2024年开展的两样本孟德尔随机化研究,分析5种暴露表型(BMI、吸烟、银屑病、IBD、SSc)对HS结局的因果效应。

主要发现

  • HS与除SSc外的所有暴露表型均存在遗传相关性:BMI rg=0.36(P<.001)、吸烟 rg=0.33(P<.001)、IBD rg=0.25(P<.001)、银屑病 rg=0.34(P<.001)、SSc rg=0.33(P=.22)。
  • MR分析支持BMI对HS的效应(β=0.87;每单位BMI的OR=1.20;95%CI 1.17-1.23;P<.001),无多效性迹象(斜率β=0.91,P<.001,截距P=.76)。
  • 吸烟显示显著因果估计(β=0.59,P<.001),但在后续敏感性分析中结果变得不确定。
  • IBD对HS存在因果效应(β=0.18,OR=1.20;95%CI 1.15-1.24;P<.001),无多效性迹象。

临床怎么用

  • 对HS患者可关注BMI管理,作为可改变的生活方式干预靶点。
  • HS患者中可考虑筛查IBD共病,反之亦然。
  • 吸烟与HS的因果关系尚不确定,但鉴于观察性关联,戒烟建议仍可能有益。

局限性

  • 研究基于欧洲人群GWAS数据,外推至其他种族需谨慎。
  • 吸烟的因果估计在敏感性分析中不确定,需进一步验证。
  • 孟德尔随机化依赖遗传工具变量假设,可能存在水平多效性等偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Smoking and obesity are associated with risk of hidradenitis suppurativa, and both are considered important environmental risk factors. However, a causal relationship remains unproven. OBJECTIVE: To primarily investigate the relationship between body mass index (BMI, calculated as weight in kilograms divided by height in meters squared) and smoking and HS, and secondarily to investigate potential relationships between 3 inflammatory diseases (psoriasis, inflammatory bowel disease [IBD], and systemic sclerosis [SSc]) and HS. DESIGN, SETTING, AND PARTICIPANTS: A mendelian randomization (MR) study conducted in 2024 on 5 exposure phenotypes (BMI, smoking, psoriasis, IBD, and SSc) on the outcome of phenotype HS was conducted. The MR analyses used large genetic White European cohorts from genome-wide association studies (GWAS) of each of the 6 phenotypes. Initial analyses were conducted May, 2024, and were updated in May, 2025. EXPOSURE: The 5 exposure phenotypes using predetermined genome-wide significant single-nucleotide variants as proxies for each particular exposure. RESULTS: The GWAS on HS included 4814 case patients and more than 1.2 million controls from Denmark, Iceland, Finland, the UK, and the US. The BMI GWAS involved 700 000 individuals from the UK Biobank and GIANT consortium. Smoking data were obtained from 1.23 million participants in an international consortium. The psoriasis GWAS analyzed 39 498 case patients and 286 769 controls from White European populations and a DNA genetic testing company. The IBD GWAS meta-analysis included 38 155 case patients and 48 485 controls from the International Inflammatory Bowel Disease (IBD) Genetics Consortium. The SSc GWAS included 9095 case patients and 17 584 controls from White European populations. Genetic correlations (rg) were found between HS and all exposure phenotypes except SSc (BMI: rg = 0.36, P < .001; smoking: rg = 0.33, P < .001; IBD: rg = 0.25, P < .001; psoriasis: rg = 0.34, P < .001; SSc: rg = 0.33, P = .22). MR analyses supported an effect of BMI on HS (β = 0.87; odds ratio [OR] per BMI unit, 1.20; 95% CI, 1.17-1.23; P < .001) without signs of pleiotropy (slope: β = 0.91, P < .001, P for intercept = .76). Smoking showed a significant causal estimate (β = 0.59, P < .001), but results became inconclusive in subsequent sensitivity analyses. Among IBD, psoriasis, and SSc, results supported a causal effect of IBD on HS (β = 0.18, OR = 1.20; 95% CI, 1.15-1.24; P < .001), without signs of pleiotropy. CONCLUSIONS AND RELEVANCE: These findings indicate causal effects of IBD and increased BMI on the risk of HS. This information may help physicians inform patients about disease risk contributed by modifiable lifestyle behaviors, which can be beneficial for planning lifestyle interventions.

来源:JAMA Dermatol,查看原文。版权归原作者所有。

引用

  1. Kjærsgaard Andersen R, Riis PT, Zachariae C, et al. Hidradenitis Suppurativa and Smoking, Obesity, Psoriasis, Inflammatory Bowel Disease, and Systemic Sclerosis: Results From A 2-Sample Mendelian Randomization Study. JAMA Dermatol. 2026. PMID: 41405899. doi:10.1001/jamadermatol.2025.5010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。